Vimarsana
Biggest News Aggregation in the World

Page 2 - Sameera Shah News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sameera Shah. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sameera Shah Today - Breaking & Trending Today

Book Box | Meet Priya Narendra: The writer who loves badly behaved women - Vimarsana News

Book Box | Meet Priya Narendra: The writer who loves badly behaved women

From reading stories of Noor Jehan and Elizabeth I to writing a rom com, this writer talks about her latest book on Indian women bosses

'Love, laugh, learn': Bosses share '10 Commandments' for success - Vimarsana News

'Love, laugh, learn': Bosses share '10 Commandments' for success

A tenet on turning ten. As ETPanache toasts its 10th anniversary, corporate bosses share why laughter, learning and loving the job are some of their top commandments

Metropolis Healthcare Q3 Results: Net profit drops 25% to Rs 27 crore - Vimarsana News

Metropolis Healthcare Q3 Results: Net profit drops 25% to Rs 27 crore

"The performance in Q3 was marginally impacted on account of heavy rainfall and floods in Chennai and adjacent areas in December 2023, leading to loss of revenues for approx. 7-8 days from Chennai region, which is one of the focus cities for Metropolis," Ameera Shah, promoter and managing director of Metropolis Healthcare said.

Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25 - Vimarsana News

Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25

Experts suggest that it presents an opportunity to address this gap, potentially increasing healthcare allocation to 2.5% of GDP from 1.6% at present, as recommended by the NITI Aayog

interim budget 2024: Budget 2024: Pharma industry seeks incentives for R&D, conducive policies - Vimarsana News

interim budget 2024: Budget 2024: Pharma industry seeks incentives for R&D, conducive policies

In the upcoming union budget 2024, the Indian pharmaceutical industry is seeking fiscal incentives to promote research and development (R&D) as it is expected to reach a market size of USD 400-450 billion by 2047. The Indian Pharmaceutical Alliance Secretary General, Sudarshan Jain, emphasized the need for continuous investments in research due to high risk and low success rates. The interim Budget 2024-25 should provide benefits in terms of direct and indirect taxes and facilitate business ease for pharma companies.